Back
62
Day Range
$26.28
$27.48
52-Week Range
$9.90
$34.29
Volume
1,383,085
50D / 200D Avg
$30.25
/
$24.06
Prev Close
$27.62
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -6.7 | 0.3 |
| P/B | 3.2 | 2.9 |
| ROE % | -49.2 | 3.7 |
| Net Margin % | -483.6 | 3.8 |
| Rev Growth 5Y % | 121.1 | 10.0 |
| D/E | 0.1 | 0.2 |
Analyst Price Target
Hold
$43.10
+58.5%
Low: $34.00
High: $50.00
Forward EPS
-$3.82
Est. Revenue
75 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$4.62
$1.45 – $10.66
|
1.3 B | 4 |
| FY2029 |
$3.04
$0.95 – $7.02
|
1 B | 4 |
| FY2028 |
$0.81
-$3.32 – $5.27
|
690 M | 11 |
Key Takeaways
Revenue grew 121.13% annually over 5 years — strong growth
Debt/Equity of 0.07 — conservative balance sheet
Negative free cash flow of -276.89M
PEG of 0.46 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 23238.80%
Capital efficient — spends only 0.70% of revenue on capex
Growth
Revenue Growth (5Y)
121.13%
Revenue (1Y)23359.93%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-49.16%
ROIC-35.26%
Net Margin-483.57%
Op. Margin-512.91%
Safety
Debt / Equity
0.07
Current Ratio12.65
Interest Coverage-73.44
Valuation
P/E Ratio
-6.73
P/B Ratio3.19
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 23359.93% | Revenue Growth (3Y) | 1402.11% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 121.13% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 70.85M | Net Income (TTM) | -342.60M |
| ROE | -49.16% | ROA | -38.09% |
| Gross Margin | 98.36% | Operating Margin | -512.91% |
| Net Margin | -483.57% | Free Cash Flow (TTM) | -276.89M |
| ROIC | -35.26% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.07 | Current Ratio | 12.65 |
| Interest Coverage | -73.44 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -6.73 | P/B Ratio | 3.19 |
| P/S Ratio | 32.56 | PEG Ratio | 0.46 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 2.31B | Enterprise Value | 2.15B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 70.85M | 302,000.0 | 314,000.0 | 1.77M | 2.96M |
| Net Income | -342.60M | -269.95M | -237.73M | -129.87M | -79.41M |
| EPS (Diluted) | -3.32 | -3.98 | -5.31 | -3.91 | -6.66 |
| Gross Profit | 69.69M | 302,000.0 | 314,000.0 | 1.77M | 2.96M |
| Operating Income | -363.40M | -299.04M | -254.45M | -134.30M | -79.73M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 899.42M | 742.40M | 490.42M | 435.09M | 203.71M |
| Total Liabilities | 177.25M | 70.76M | 48.40M | 40.03M | 15.99M |
| Shareholders' Equity | 722.17M | 671.64M | 442.02M | 395.06M | 187.72M |
| Total Debt | 50.69M | 21.10M | 21.05M | 5.26M | 520,000.0 |
| Cash & Equivalents | 212.38M | 99.59M | 102.83M | 155.58M | 42.30M |
| Current Assets | 894.23M | 738.46M | 486.48M | 424.55M | 200.16M |
| Current Liabilities | 70.70M | 47.87M | 26.64M | 33.35M | 13.64M |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Full Throttle
#25 of 146
Recent Activity
Entered
Full Throttle
Mar 24, 2026